Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APOQUEL DIN 02530651

Status: Marketed
Holder: ZOETIS CANADA INC
Molecule: OCLACITINIB (OCLACITINIB MALEATE)

Health Canada record

Active ingredient(s)OCLACITINIB (OCLACITINIB MALEATE) 3.6 MG
Dosage formTablet (Chewable)
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date18-Jul-2023
Current status date18-Jul-2023
SourceHealth Canada DPD

Establishment licence of the holder

Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing OCLACITINIB (OCLACITINIB MALEATE)

DINProductCompanyFormStrengthStatus
02427885APOQUELZOETIS CANADA INCTabletOCLACITINIB (OCLACITINIB MALEATE) 3.6 MGMarketed
02427893APOQUELZOETIS CANADA INCTabletOCLACITINIB (OCLACITINIB MALEATE) 5.4 MGMarketed
02427907APOQUELZOETIS CANADA INCTabletOCLACITINIB (OCLACITINIB MALEATE) 16 MGMarketed
02530678APOQUELZOETIS CANADA INCTablet (Chewable)OCLACITINIB (OCLACITINIB MALEATE) 5.4 MGMarketed
02530686APOQUELZOETIS CANADA INCTablet (Chewable)OCLACITINIB (OCLACITINIB MALEATE) 16 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
329142024-03-20Supplement to a New Drug Submission (SNDS)Addition of a drug substance supplier
289482022-09-14Supplement to a New Drug Submission (SNDS)New dosage form (chewable tablets)
Request a quote for APOQUEL

How to read a Canadian DIN record